SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 3 — Focused Visit (Follow-up) — Jim Thorpe

PatientJim Thorpe
Date of birth1963-05-28
IdentifiersMRN HR-ML011-SYN; SSN (made up) 000-11-9036
Document date2026-07-13
AuthorNolan Fairbanks, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Two weeks after excision of the lip cancer: pathology, wound check, surveillance plan, lipids, and cardiac rehabilitation. [S]

History of Present Illness

Mr. Thorpe returns two weeks after V-excision of the lower lip cancer by Dr. Ferrante. The CT of the neck before surgery showed no enlarged or abnormal lymph nodes. He took acetaminophen for three days after the operation and needed nothing stronger. The stitches were removed last week. His lip feels a little tight but he can whistle, drink from a cup and speak clearly. He has had no chest tightness since the first week of his medicines and has not used nitroglycerin. He took aspirin throughout and had only slight oozing on the first night. He is keen to start cardiac rehabilitation. [S]

ElementDetail
SurgeryV-excision two weeks ago; stitches out; lip function normal
Neck CT before surgeryNo enlarged or abnormal lymph nodes
AnginaNone for four weeks
MedicinesAspirin, atorvastatin 80 mg and metoprolol taken daily

Review of Systems

SystemResultFinding
Ears, nose, mouth, and throatPositiveLip slightly tight; no pain, drooling, or trouble eating
CardiovascularNegativeNo chest tightness, palpitations, or leg swelling
MusculoskeletalNegativeNo muscle aches on atorvastatin
NeurologicalNegativeLip sensation normal

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Aspirin 81 mg delayed-release oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-06-08activeS
Atorvastatin 80 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-06-08activeS
Metoprolol succinate 25 mg extended-release oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-06-08activeS
Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue for chest pain, repeated every 5 minutes up to 3 tabletsOne tablet under the tongue as needed for chest pain; call 911 if pain persists 5 minutes after the first tabletSublingual route2026-06-08activeS
Ezetimibe 10 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-07-13activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-07-13Body height185cmS
2026-07-13Body weight93kgS
2026-07-13Body mass index (BMI) [Ratio]27.2kg/m2S
2026-07-13Systolic blood pressure128mm[Hg]S
2026-07-13Diastolic blood pressure78mm[Hg]S
2026-07-13Heart rate62/minS
2026-07-13Respiratory rate14/minS
2026-07-13Body temperature36.6CelS
2026-07-13Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-07-13Cholesterol [Mass/volume] in Serum or Plasma136mg/dL<=199 mg/dLNormalS
2026-07-13Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation68mg/dLBelow 100 mg/dL in general; secondary-prevention goal below 55 mg/dLNormalS
2026-07-13Cholesterol in HDL [Mass/volume] in Serum or Plasma42mg/dL>=40 mg/dLNormalS
2026-07-13Triglyceride [Mass/volume] in Serum or Plasma130mg/dL<=149 mg/dLNormalS
2026-07-13Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma31U/L7-55 U/LNormalS

Physical Exam

Vital signs recorded on 2026-07-13; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 128/78, pulse 62; weight 93.0 kg
Head and neckLower lip scar healing well, vermilion line aligned; good lip closure; no nodularity; mouth normal; no neck nodes
CardiovascularRegular rhythm; no murmur

Problems

ProblemClinical statusVerificationCodeProvenance
Non-healing lesion of the left lower lip for about three months: a 1.2 cm firm, crusted ulcer on the vermilion that bleeds when touched, on a background of dry, scaly lips from years of outdoor work; no numbness of the lip or chin and no palpable neck nodes. Suspicious for squamous cell carcinoma; incisional biopsy taken today and otolaryngology consultation bookedresolvedconfirmed K13.0S — Synthetic presenting problem linked to his documented lip cancer; superseded by the biopsy diagnosis.
Chronic coronary disease with stable exertional angina: tightness in the chest when walking uphill or carrying loads for about a year, relieved by two or three minutes of rest, never at rest; heart attack eight years ago, treated in hospital, with no regular care or medicines since. Resting ECG: sinus rhythm with Q waves in the inferior leads. Synthetic modern episode linked to his documented heart attacksactiveconfirmed I25.119S — Synthetic modern coding of the documented heart disease.
Squamous cell carcinoma of the left lower lip (external vermilion): invasive, well-differentiated keratinizing squamous cell carcinoma on incisional biopsy; 1.2 cm, no palpable neck nodes; clinical stage T1 N0 (AJCC 8th edition, lip and oral cavity). Synthetic modern episode linked to his documented lip canceractiveconfirmed C00.1S — Synthetic modern diagnosis; the cited sources do not record the type of his lip cancer.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationExamination of the lips, mouth, and neckEvery 1 to 3 months in year 1, 2 to 6 months in year 2, 4 to 8 months in years 3 to 5, then yearlyCompleted todayScar healing; no nodularity; no neck nodes
LaboratoryPathology: type, margins, depth of invasion, perineural and lymphovascular invasionFull pathology after excisionCompleted todaypT1, depth of invasion 2.5 mm, margins clear (closest 6 mm), no perineural or lymphovascular invasion
ImagingImaging of the primary site and neckBefore treatment as indicated; afterwards only for symptoms or findingsUp to dateNeck CT before surgery: no abnormal nodes; no routine imaging afterwards
LaboratoryTSHEvery 6 to 12 months only if the neck was irradiatedNot indicatedNeck not irradiated
Self-managementSun protection of the lips and skinEvery visitCompleted todayUsing lip balm with sunscreen and a hat
Self-managementTobacco and alcohol useEvery visitCompleted todayTobacco-free; alcohol one or two beers some weekends
ReferralDental evaluationAfter diagnosis, then routineDueDental check-up advised; he will look into options
ExaminationBlood pressure (goal below 130/80)Every visitCompleted today128/78
ExaminationWeight, BMI, and physical activityEvery visitCompleted today93.0 kg, BMI 27.2
SurveyAngina frequency and nitroglycerin useEvery visitCompleted todayNone for four weeks; no nitroglycerin
Medication safetyAdherence and side effects: aspirin, high-intensity statin, beta-blockerEvery visitCompleted todayAll taken daily; no muscle symptoms
LaboratoryLipid panel4 to 12 weeks after starting or changing lipid therapy, then every 3 to 12 months; goal LDL below 55 mg/dLCompleted todayFive weeks after starting atorvastatin: total cholesterol 136, LDL 68, HDL 42, triglycerides 130 mg/dL; ezetimibe added
LaboratoryALT on statinBaseline; repeat only for symptomsCompleted today31 U/L
ReferralCardiac rehabilitationAfter a heart attack or for stable angina: up to 36 sessionsReferredStarting this month, three sessions a week

Goal progress:

Guideline basis: NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers (cancer of the lip and oral cavity) (2026); 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023); 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol (2018); CMID: Clinical Monitoring Intelligence Database, ischemic heart disease monograph (2026)

Follow-up: Cardiac rehabilitation three times a week. Visit in about ten weeks with a lipid panel and lip examination. Next scheduled visit 2026-09-21: coronary disease review in cardiac rehabilitation, lipid recheck after ezetimibe, and lip surveillance. [S]